Symbol="APLS"
AssetType="Common Stock"
Name="Apellis Pharmaceuticals Inc"
Description="Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through inhibition of the complement system for autoimmune and inflammatory diseases. The company is headquartered in Waltham, Massachusetts."
CIK="1492422"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="6400 WESTWIND WAY, SUITE A, CRESTWOOD, KY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3772042000"
EBITDA="-610880000"
PERatio="None"
PEGRatio="None"
BookValue="2.938"
DividendPerShare="0"
DividendYield="0"
EPS="-5.9"
RevenuePerShareTTM="1.63"
ProfitMargin="0"
OperatingMarginTTM="-3.319"
ReturnOnAssetsTTM="-0.399"
ReturnOnEquityTTM="-1.933"
RevenueTTM="184533000"
GrossProfitTTM="69786000"
DilutedEPSTTM="-5.9"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="4.818"
AnalystTargetPrice="64"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="51.26"
PriceToBookRatio="17.67"
EVToRevenue="42.79"
EVToEBITDA="-8.03"
Beta="1.17"
num_52WeekHigh="94.75"
num_52WeekLow="19.83"
num_50DayMovingAverage="65.35"
num_200DayMovingAverage="63.63"
SharesOutstanding="116457000"
DividendDate="None"
ExDividendDate="None"
symbol="APLS"
open="27.03"
high="33.30"
low="26.90"
price="32.39"
volume="15927988.00"
latest_trading_day="2023-08-11"
previous_close="27.01"
change="5.38"
change_percent="19.9185%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="20"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="80"
Volume_recent_avg="3245424"
Change_recent_avg="0.01"
Delta_recent_avg="3.21"
Variance_recent_avg="1.61"
Change_ratio_recent_avg="-0.27"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="80"
Aroon_momentum_negative="20"
image_negative_thumbnail_id_1="112"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0064.jpeg"
image_negative_thumbnail_id_2="1117"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0150.jpeg"
image_neutral_thumbnail_id_1="432"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="575"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0024.jpeg"
image_positive_thumbnail_id_1="971"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0133.jpeg"
image_positive_thumbnail_id_2="653"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0055.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
